These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 16997053

  • 21. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y, Koyama H.
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [Abstract] [Full Text] [Related]

  • 22. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
    Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyrén O, Fored CM.
    Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
    [Abstract] [Full Text] [Related]

  • 23. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Hanai K, Tanaka N, Ishii A, Iwamoto Y.
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [Abstract] [Full Text] [Related]

  • 24. [Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].
    Pintó X, Corbella E, Figueras R, Biarnés J, Ricart W, Morales C, Falkon L, Masana L, ESODIAH study group.
    Rev Esp Cardiol; 2007 Mar; 60(3):251-8. PubMed ID: 17394870
    [Abstract] [Full Text] [Related]

  • 25. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study.
    Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC.
    Arch Intern Med; 2007 Mar; 165(22):2659-65. PubMed ID: 16344425
    [Abstract] [Full Text] [Related]

  • 26. Renal artery stenosis by three-dimensional magnetic resonance angiography in type 2 diabetics with uncontrolled hypertension and chronic renal insufficiency: prevalence and effect on renal function.
    Myers DI, Poole LJ, Imam K, Scheel PJ, Eustace JA.
    Am J Kidney Dis; 2003 Feb; 41(2):351-9. PubMed ID: 12552496
    [Abstract] [Full Text] [Related]

  • 27. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.
    Linnemann B, Janka HU.
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):215-22. PubMed ID: 12845560
    [Abstract] [Full Text] [Related]

  • 28. Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
    Coughlan MT, Forbes JM.
    Am J Nephrol; 2011 Jun; 34(1):9-17. PubMed ID: 21654162
    [Abstract] [Full Text] [Related]

  • 29. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ.
    J Diabetes Complications; 2012 Jun; 26(5):407-12. PubMed ID: 22677793
    [Abstract] [Full Text] [Related]

  • 30. Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes.
    Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K.
    In Vivo; 2003 Jun; 17(2):177-80. PubMed ID: 12792982
    [Abstract] [Full Text] [Related]

  • 31. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M.
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [Abstract] [Full Text] [Related]

  • 32. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
    So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC.
    Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
    [Abstract] [Full Text] [Related]

  • 33. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M, Tarnow I, Michelson AD, Jorsal A, Frelinger AL, Parving HH, Rossing P, Tarnow L.
    Platelets; 2010 Sep; 21(7):525-32. PubMed ID: 20701458
    [Abstract] [Full Text] [Related]

  • 34. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E, Lambers Heerspink HJ, Lutgers HL, Bakker SJ, Vart P, Wolffenbuttel BH, Umanath K, Lewis JB, de Zeeuw D, Gansevoort RT.
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [Abstract] [Full Text] [Related]

  • 35. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL, Lin HD.
    Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
    [Abstract] [Full Text] [Related]

  • 36. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K, Podracká L, Heidland A, Schinzel R.
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [Abstract] [Full Text] [Related]

  • 37. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [Abstract] [Full Text] [Related]

  • 38. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
    Murussi M, Campagnolo N, Beck MO, Gross JL, Silveiro SP.
    Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
    [Abstract] [Full Text] [Related]

  • 39. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome.
    Linnemann B, Voigt W, Nobel W, Janka HU.
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979
    [Abstract] [Full Text] [Related]

  • 40. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
    Hsieh MC, Tien KJ, Perng DS, Hsiao JY, Chang SJ, Liang HT, Chen HC, Tu ST.
    Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.